Abstract
In this brief report, we offer a concise overview on current cancer epidemiology garnered from the official databases of World Health Organization and American Cancer Society and provide recent information on frequency, mortality, and survival expectancy of the 15 leading types of cancers worldwide. Overall, cancer poses the highest clinical, social, and economic burden in terms of cause-specific Disability-Adjusted Life Years (DALYs) among all human diseases. The overall 0–74 years risk of developing cancer is 20.2% (22.4% in men and 18.2% in women, respectively). A total number of 18 million new cases have been diagnosed in 2018, the most frequent of which are lung (2.09 million cases), breast (2.09 million cases), and prostate (1.28 million cases) cancers. Beside sex-specific malignancies, the ratio of frequency between men and women is >1 for all cancers, except thyroid (i.e., 0.30). As concerns mortality, cancer is the second worldwide cause of death (8.97 million deaths) after ischemic heart disease, but will likely become the first in 2060 (~18.63 million deaths). Lung, liver, and stomach are the three most deadly cancers in the general population, while lung and breast cancers are the leading causes of cancer related-mortality in men and women, respectively. Prostate and thyroid cancers have the best prognosis, with 5-year survival ~100%, while esophagus, liver, and especially pancreas cancers have the worst prognosis, typically <20% at 5 years. We hope that this report will provide fertile ground for addressing health-care interventions aimed at preventing, diagnosing, and managing cancer around the world.
Article PDF
Avoid common mistakes on your manuscript.
References
Montagnana M, Lippi G. Cancer diagnostics: current concepts and future perspectives. Ann Transl Med 2017;5;268.
World Health Organization. Global Health Estimates 2016: disease burden by cause, age, sex, by country and by region, 2000–2016. Geneva: World Health Organization; 2018. Available from: https://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html (accessed July 9, 2019).
International Agency for Research on Cancer. Global cancer observatory - cancer fact sheets. Available from: http://gco.iarc.fr/today/fact-sheets-cancers (accessed July 9, 2019).
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392;1789–858.
World Health Organization. Projections of mortality and causes of death, 2016 to 2060. Available from: https://www.who.int/healthinfo/global_burden_disease/projections/en/ (accessed July 9, 2019).
American Cancer Society. Cancer statistics. Available from: https://www.cancer.org/cancer/all-cancer-types.html (accessed July 9, 2019).
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018;391;1023–75.
Domínguez-Vigil IG, Moreno-Martínez AK, Wang JY, Roehrl MHA, Barrera-Saldaña HA. The dawn of the liquid biopsy in the fight against cancer. Oncotarget 2017;9;2912–22.
Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, et al. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci) 2018;6;79–100.
Zhang H, Chen J. Current status and future directions of cancer immunotherapy. J Cancer 2018;9;1773–81.
Lippi G, Mattiuzzi C, Cervellin G. Is digital epidemiology the future of clinical epidemiology? J Epidemiol Glob Health 2019;9;146.
Author information
Authors and Affiliations
Corresponding author
Additional information
Data availability statement: The raw data used in this study may be requested from the authors.
Rights and permissions
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
About this article
Cite this article
Mattiuzzi, C., Lippi, G. Current Cancer Epidemiology. J Epidemiol Glob Health 9, 217–222 (2019). https://doi.org/10.2991/jegh.k.191008.001
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2991/jegh.k.191008.001